Chris BUYSE
Biotech Expert, Fund+ Managing Partner
Chris BUYSE was CFO at ThromboGenics NV from September 2006 until June 2014. He has 25 years of experience in international company finance and in running and establishing best financial practice. He is currently serving as an independent Board Member of a few companies, mostly active in life sciences such as Celyad, Bone Therapeutics, Iteos and Bioxodes.